Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection

PLoS Neglected Tropical Diseases

Volumn 9, Issue 11, 2015, Pages

  Choy, Milly M ^a   Zhang, Summer L ^a   Costa, Vivian V ^b   Tan, Hwee Cheng ^a   Horrevorts, Sophie ^c   Ooi, Eng Eong ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; FC RECEPTOR; INITIATION FACTOR 2ALPHA; PROTEASOME; ANTIVIRUS AGENT; UBIQUITIN; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; DENGUE VIRUS 2; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN PHOSPHORYLATION; UPREGULATION; VIRAL GENETICS; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DENGUE; DISEASE MODEL; DRUG EFFECTS; HOST PATHOGEN INTERACTION; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; SPLEEN; VIROLOGY; VIRUS ASSEMBLY; VIRUS LOAD; VIRUS RELEASE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; ANTIVIRAL AGENTS; BORTEZOMIB; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE, INBRED C57BL; MONOCYTES; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, VIRAL; SPLEEN; UBIQUITIN; VIRAL LOAD; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84949514477     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004058     Document Type: Article

References (45)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504–507. doi: 10.1038/nature12060 23563266
2. Villar L, Dayan GH, Arredondo-Garcia JL, Rivera DM, Cunha R, et al. (2015) Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med 372: 113–123. doi: 10.1056/NEJMoa1411037 25365753
3. Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, et al. (2014) Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384: 1358–1365. doi: 10.1016/S0140-6736(14)61060-6 25018116
4. Guzman MG, Kouri G, Valdes L, Bravo J, Vazquez S, et al. (2002) Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica 11: 223–227. 12049030
5. Kliks SC, Nimmanitya S, Nisalak A, Burke DS, (1988) Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 38: 411–419. 3354774
6. Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, et al. (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis 4: e785. doi: 10.1371/journal.pntd.0000785 20706626
7. Nguyen NM, Tran CN, Phung LK, Duong KT, Huynh Hle A, et al. (2013) A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis 207: 1442–1450. doi: 10.1093/infdis/jis470 22807519
8. Low JG, Sung C, Wijaya L, Wei Y, Rathore AP, et al. (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14: 706–715. doi: 10.1016/S1473-3099(14)70730-3 24877997
9. Fischl W, Bartenschlager R, (2011) Exploitation of cellular pathways by Dengue virus. Curr Opin Microbiol 14: 470–475. doi: 10.1016/j.mib.2011.07.012 21798792
10. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, et al. (2009) Discovery of insect and human dengue virus host factors. Nature 458: 1047–1050. doi: 10.1038/nature07967 19396146
11. Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, et al. (2008) RNA interference screen for human genes associated with West Nile virus infection. Nature 455: 242–U267. doi: 10.1038/nature07207 18690214
12. Krishnan MN, Garcia-Blanco MA, (2014) Targeting host factors to treat West Nile and dengue viral infections. Viruses 6: 683–708. doi: 10.3390/v6020683 24517970
13. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, et al. (2007) Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 1: e86. 18060089
14. Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V, (2010) The Ubiquitin-Proteasome Pathway Is Important for Dengue Virus Infection in Primary Human Endothelial Cells. J Proteome Res 9: 4960–4971. doi: 10.1021/pr100219y 20718508
15. Raghavan B, Ng ML, (2013) West nile virus and Dengue virus capsid protein negates the antiviral activity of human Sec3 protein Through The Proteasome Pathway. Cell Microbiol.
16. Sessions OM, Tan Y, Goh KC, Liu Y, Tan P, et al. (2013) Host cell transcriptome profile during wild-type and attenuated dengue virus infection. PLoS Negl Trop Dis 7: e2107. doi: 10.1371/journal.pntd.0002107 23516652
17. Chu JJH, Ng ML, (2004) Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J Virol 78: 10543–10555. 15367621
18. Hicke L, (2001) Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol 2: 195–201. 11265249
19. Fernandez-Garcia MD, Meertens L, Bonazzi M, Cossart P, Arenzana-Seisdedos F, et al. (2011) Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. J Virol 85: 2980–2989. doi: 10.1128/JVI.02483-10 21191016
20. Booth JW, Kim MK, Jankowski A, Schreiber AD, Grinstein S, (2002) Contrasting requirements for ubiquitylation during Fc receptor-mediated endocytosis and phagocytosis. EMBO J 21: 251–258. 11823418
21. Chan KR, Ong EZ, Tan HC, Zhang SL, Zhang Q, et al. (2014) Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proc Natl Acad Sci USA 111: 2722–2727. doi: 10.1073/pnas.1317454111 24550301
22. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592–5595. 3106339
23. Greenberg S, Chang P, Silverstein SC, (1993) Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J Exp Med 177: 529–534. 7678851
24. Chan KR, Zhang SL, Tan HC, Chan YK, Chow A, et al. (2011) Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection. Proc Natl Acad Sci USA 108: 12479–12484. doi: 10.1073/pnas.1106568108 21746897
25. Zhang SL, Tan HC, Hanson BJ, Ooi EE, (2010) A simple method for Alexa Fluor dye labelling of dengue virus. J Virol Methods 167: 172–177. doi: 10.1016/j.jviromet.2010.04.001 20399231
26. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, et al. (2007) Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol 81: 12019–12028. 17728239
27. Inoue M, Chang L, Hwang J, Chiang SH, Saltiel AR, (2003) The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin. Nature 422: 629–633. 12687004
28. Chen Z, Lin X, Zhang Z, Huang J, Fu S, et al. (2011) EXO70 protein influences dengue virus secretion. Microbes Infect 13: 143–150. doi: 10.1016/j.micinf.2010.10.011 21034848
29. Dever TE, (2002) Gene-specific regulation by general translation factors. Cell 108: 545–556. 11909525
30. Sonenberg N, Hinnebusch AG, (2009) Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136: 731–745. doi: 10.1016/j.cell.2009.01.042 19239892
31. Wek RC, Jiang HY, Anthony TG, (2006) Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 34: 7–11. 16246168
32. St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN, (2013) Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. eLife 2: e00481. doi: 10.7554/eLife.00481 23638300
33. Glickman MH, Ciechanover A, (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373–428. 11917093
34. Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Jr.Lee KP, et al. (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107: 4907–4916. 16507771
35. Hampton RY, (2000) ER stress response: getting the UPR hand on misfolded proteins. Curr Biol 10: R518–521. 10898996
36. Credle JJ, Finer-Moore JS, Papa FR, Stroud RM, Walter P, (2005) On the mechanism of sensing unfolded protein in the endoplasmic reticulum. Proc Natl Acad Sci USA 102: 18773–18784. 16365312
37. Umareddy I, Pluquet O, Wang QY, Vasudevan SG, Chevet E, et al. (2007) Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol J 4: 91. 17888185
38. Wang YE, Park A, Lake M, Pentecost M, Torres B, et al. (2010) Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog 6: e1001186. doi: 10.1371/journal.ppat.1001186 21085610
39. Mimnaugh EG, Chen HY, Davie JR, Celis JE, Neckers L, (1997) Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Biochemistry 36: 14418–14429. 9398160
40. Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, et al. (2000) Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 97: 13057–13062. 11087859
41. Patnaik A, Chau V, Wills JW, (2000) Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci USA 97: 13069–13074. 11087861
42. Halstead SB, (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239: 476–481. 3277268
43. Aye KS, Charngkaew K, Win N, Wai KZ, Moe K, et al. (2014) Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from Myanmar. Hum Pathol 45: 1221–1233. doi: 10.1016/j.humpath.2014.01.022 24767772
44. Durbin AP, Vargas MJ, Wanionek K, Hammond SN, Gordon A, et al. (2008) Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376: 429–435. doi: 10.1016/j.virol.2008.03.028 18452966
45. Moreau P, (2014) Oral therapy for multiple myeloma: ixazomib arriving soon. Blood 124: 986–987. doi: 10.1182/blood-2014-06-581611 25124778